Tambur, Anat R.Crespo Barrio, MartaNickerson, Peter2024-03-152024-03-152018Tambur AR, Bestard O, Campbell P, Chong AS, Barrio MC, Ford ML, et al. Sensitization in transplantation: assessment of risk 2022 working group meeting report. Am J Transplant. 2023 Jan;23(1):133-49. DOI: 10.1016/j.ajt.2022.11.0091600-6135http://hdl.handle.net/10230/59433The Sensitization in Transplantation: Assessment of Risk workgroup is a collaborative effort of the American Society of Transplantation and the American Society of Histocompatibility and Immunogenetics that aims at providing recommendations for clinical testing, highlights gaps in current knowledge, and proposes areas for further research to enhance histocompatibility testing in support of solid organ transplantation. This report provides updates on topics discussed by the previous Sensitization in Transplantation: Assessment of Risk working groups and introduces 2 areas of exploration: non–human leukocyte antigen antibodies and utilization of human leukocyte antigen antibody testing measurement to evaluate the efficacy of antibody-removal therapies.application/pdfeng© 2022 The Author(s). Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Sensitization in transplantation: Assessment of risk 2022 working group meeting reportinfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.ajt.2022.11.009Clinical research/practiceTranslational research/scienceHistocompatibilitySolid organ transplantationImmunobiologyAlloantibodyB-cell biologyDesensitizationGuidelinesT-cell biologyinfo:eu-repo/semantics/openAccess